Diltiazem reduces pulmonary arterial pressures in recurrent pulmonary hypertension associated with pulmonary hypoplasia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (10)
High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.
1987 • 365 citations
The Acute Administration of Vasodilators in Primary Pulmonary Hypertension: Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension
1989 • 188 citations
Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.
1993 • 77 citations
Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension
1993 • 40 citations
Acute effects of oxygen, nifedipine, and diltiazem in patients with cystic fibrosis and mild pulmonary hypertension
1989 • 33 citations
Nitric oxide reversal of recurrent pulmonary hypertension and respiratory failure in an infant with CDH after successful ECMO therapy
1995 • 26 citations
Congenital diaphragmatic hernia: impact of prostanoids in the perioperative period.
1990 • 21 citations
Differential Therapy with Calcium Antagonists in Pulmonary Hypertension Secondary to COPD
1990 • 20 citations
Semotiadil inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension
1995 • 12 citations
Effects of Single Intravenous Administration of Urapidil and Diltiazem in Patients with Nonfixed Pulmonary Hypertension Secondary to Chronic Obstructive Lung Disease
1994 • 6 citations